US 9057069
Compositions and methods for inhibiting expression of Eg5 gene
granted A61PA61P35/00A61P43/00
Quick answer
US patent 9057069 (Compositions and methods for inhibiting expression of Eg5 gene) held by Alnylam Pharmaceuticals, Inc. expires Mon Jun 11 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Alnylam Pharmaceuticals, Inc.
- Grant date
- Tue Jun 16 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 11 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 27
- CPC classes
- A61P, A61P35/00, A61P43/00